Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
29.36
-0.18 (-0.61%)
At close: Mar 5, 2026, 4:00 PM EST
28.86
-0.50 (-1.70%)
Pre-market: Mar 6, 2026, 4:22 AM EST
Celldex Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$44.50
Upside
+51.57%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $30 → $34 | Hold | Maintains | $30 → $34 | +15.80% | Mar 2, 2026 |
| Stifel | Stifel | Strong Buy Reiterates $58 → $68 | Strong Buy | Reiterates | $58 → $68 | +131.61% | Feb 26, 2026 |
| Barclays | Barclays | Sell Maintains $21 → $24 | Sell | Maintains | $21 → $24 | -18.26% | Dec 17, 2025 |
| Barclays | Barclays | Sell Maintains $25 → $21 | Sell | Maintains | $25 → $21 | -28.47% | Nov 11, 2025 |
| Mizuho | Mizuho | Buy Initiates $48 | Buy | Initiates | $48 | +63.49% | Oct 21, 2025 |
| Barclays | Barclays | Sell Initiates $25 | Sell | Initiates | $25 | -14.85% | Oct 13, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $62 | Strong Buy | Maintains | $62 | +111.17% | Sep 17, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $44 → $38 | Buy | Maintains | $44 → $38 | +29.43% | Aug 20, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $56 → $48 | Strong Buy | Maintains | $56 → $48 | +63.49% | Aug 20, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $64 → $62 | Strong Buy | Maintains | $64 → $62 | +111.17% | Aug 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $42 | Strong Buy | Maintains | $50 → $42 | +43.05% | Aug 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +70.30% | Jun 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +70.30% | Jun 13, 2025 |
| UBS | UBS | Strong Buy Maintains $44 → $38 | Strong Buy | Maintains | $44 → $38 | +29.43% | May 9, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $36 → $31 | Hold | Maintains | $36 → $31 | +5.59% | May 9, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $46 → $43 | Buy | Maintains | $46 → $43 | +46.46% | May 9, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.